Company Filing History:
Years Active: 2018
Title: Jurgen Del Favero: Innovator in Antibody Library Development
Introduction
Jurgen Del Favero is a notable inventor based in Tienen, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. His innovative work has implications for therapeutic applications and research in immunology.
Latest Patents
Jurgen Del Favero holds a patent for "Highly diverse combinatorial antibody libraries." This patent discloses an immune library obtained from a Camelid species, containing antibody chains belonging to at least seven human germline antibody chains. The presence of a large number of human germline antibody chain families in the library enhances its usefulness in producing antibodies to human target antigens. The antibodies generated from this library exhibit low inherent immunogenicity, making them suitable for therapeutic use.
Career Highlights
Jurgen Del Favero is currently employed at Argenx Bvba, a company known for its focus on developing innovative therapies for severe autoimmune diseases and cancer. His work at Argenx has positioned him as a key player in the biotechnology sector, contributing to advancements in antibody technology.
Collaborations
Throughout his career, Jurgen has collaborated with esteemed colleagues, including Johannes Joseph Wilhelmus De Haard and Christophe Frederic Jerome Blanchetot. These collaborations have further enriched his research and development efforts in the field of antibody libraries.
Conclusion
Jurgen Del Favero's contributions to the development of combinatorial antibody libraries represent a significant advancement in biotechnology. His innovative approach and collaboration with other experts in the field continue to drive progress in antibody research and therapeutic applications.